BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16244317)

  • 21. Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells.
    Chen W; Xiao BK; Liu JP; Chen SM; Tao ZZ
    Cancer Sci; 2010 Aug; 101(8):1769-76. PubMed ID: 20545697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells.
    Tilman G; Loriot A; Van Beneden A; Arnoult N; Londoño-Vallejo JA; De Smet C; Decottignies A
    Oncogene; 2009 Apr; 28(14):1682-93. PubMed ID: 19252523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere exchange and asymmetric segregation of chromosomes can account for the unlimited proliferative potential of ALT cell populations.
    Blagoev KB; Goodwin EH
    DNA Repair (Amst); 2008 Feb; 7(2):199-204. PubMed ID: 18006387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells.
    Compton SA; Choi JH; Cesare AJ; Ozgür S; Griffith JD
    Cancer Res; 2007 Feb; 67(4):1513-9. PubMed ID: 17308089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
    Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
    Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
    Jiang WQ; Zhong ZH; Henson JD; Neumann AA; Chang AC; Reddel RR
    Mol Cell Biol; 2005 Apr; 25(7):2708-21. PubMed ID: 15767676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple mechanisms of telomere maintenance exist in liposarcomas.
    Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
    Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pericentromeric instability and spontaneous emergence of human neoacrocentric and minute chromosomes in the alternative pathway of telomere lengthening.
    Gagos S; Chiourea M; Christodoulidou A; Apostolou E; Raftopoulou C; Deustch S; Jefford CE; Irminger-Finger I; Shay JW; Antonarakis SE
    Cancer Res; 2008 Oct; 68(19):8146-55. PubMed ID: 18829574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A postulated role of p130 in telomere maintenance by human papillomavirus oncoprotein E7.
    Zhang W; Tian Y; Chen JJ; Zhao W; Yu X
    Med Hypotheses; 2012 Aug; 79(2):178-80. PubMed ID: 22595804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of recombination in telomere length maintenance.
    Royle NJ; Méndez-Bermúdez A; Gravani A; Novo C; Foxon J; Williams J; Cotton V; Hidalgo A
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):589-95. PubMed ID: 19442255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms.
    Johnson JE; Gettings EJ; Schwalm J; Pei J; Testa JR; Litwin S; von Mehren M; Broccoli D
    Cancer Res; 2007 Oct; 67(19):9221-8. PubMed ID: 17909028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
    Costa A; Daidone MG; Daprai L; Villa R; Cantù S; Pilotti S; Mariani L; Gronchi A; Henson JD; Reddel RR; Zaffaroni N
    Cancer Res; 2006 Sep; 66(17):8918-24. PubMed ID: 16951210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural aspects of RecA-dependent homologous strand exchange involving human telomeric DNA.
    Zein SS; Levene SD
    Biochemistry; 2005 Mar; 44(12):4817-28. PubMed ID: 15779908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere dysfunction and telomerase activation in cancer--a pathological paradox?
    Calcagnile O; Gisselsson D
    Cytogenet Genome Res; 2007; 118(2-4):270-6. PubMed ID: 18000380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
    Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
    Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.